as on March 6, 2026 at 9:31 pm IST
Day's Low
Day's High
5.26%
Downside
0.61%
Upside
52 Week's Low
52 Week's High
9.51%
Downside
58.80%
Upside
as on March 6, 2026 at 4:01 pm IST
Market Cap
₹1,074.59 Cr
Return on Equity (ROE)
19
PE Ratio (TTM)
18.45
Return on capital employed (ROCE)
25.53
Industry PE ratio
47.95
Beta (LTM)
0.81
P/B Ratio
5.08
Dividend Yield
0.25
PEG Ratio
1.63
Quarterly Earnings Growth YOY
66.22
EPS (TTM)
55.66
Sector
Healthcare
Book Value
313.27
as on March 6, 2026 at 4:01 pm IST
3B Blackbio DX in the last 5 years
Lowest (1.88x)
March 31, 2021
Today (18.45x)
March 6, 2026
Industry (47.95x)
March 6, 2026
Highest (43.02x)
December 11, 2024
Today’s Price to Earnings Ratio: 18.45x
Compare market cap, revenue, PE, and other key metrics of 3B Blackbio DX with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,074.59 | 60.66% | 0.51 | 47 | 96 | |
| BUY | 29,838.42 | 33.46% | 0.60 | 481 | 3,692 | |
| NA | 45.25 | 214.57% | 0.64 | 3 | 16 | |
| NA | 45.37 | 42.18% | 0.00 | 5 | 16 | |
| BUY | 1,624.03 | 7.95% | 0.67 | 1 | 1,086 |
Search interest for 3B Blackbio DX Ltd Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of 3B Blackbio DX.
3B Blackbio DX Ltd’s net profit jumped 62.16% since last year same period to ₹21.73Cr in the Q3 2025-2026. On a quarterly growth basis, 3B Blackbio DX Ltd has generated 47.72% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, 3B Blackbio DX Ltd has declared dividend of ₹4.00 per share on 28 May 2025 - translating a dividend yield of 0.55%.
Read More about DividendsCheck stock indices that include 3B Blackbio DX.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 54.26% to 54.28% in Dec 2025 quarter
Best in 3 Years
![]()
In the last 3 years, 3B Blackbio has outperformed top 5 stocks with highest market-cap in Agricultural Chemicals
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 26.55 Cr → 55.93 Cr (in ₹), with an average increase of 31.1% per quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 8.4 Cr → 21.73 Cr (in ₹), with an average increase of 26.7% per quarter
Against Peers
![]()
In the last 1 year, Coromandel International Ltd has given 19.1% return, outperforming this stock by 52.4%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 41.28% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 1 month, 3B Blackbio stock has moved down by -23.0%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.64% to 2.57% in Dec 2025 quarter
| Organisation | 3B Blackbio DX Ltd |
| Industry | Healthcare |
| CEO | D K Dubey |
| E-voting on shares | Click here to vote |
3B Blackbio DX share price today stands at ₹1272 as on at the close of the market. 3B Blackbio DX share today touched a day high of ₹1279.8 and a low of ₹1205.1.
3B Blackbio DX touched a 52 week high of ₹2019.9 and a 52 week low of ₹1151. 3B Blackbio DX share price today i.e. is closed at ₹1272, which is -37.03% down from its 52 week high and 10.51% up from its 52 week low.
3B Blackbio DX market capitalisation is ₹1,074.59 Cr as on .
To buy 3B Blackbio DX shares, you need to follow these steps:
3B Blackbio DX trading volume is 5,814.00 as on . This means that 5,814.00 shares of 3B Blackbio DX were bought and sold on the stock market during today's trading session.